Last Posted: Jun 06, 2018
- 2018 ASCO: Neoadjuvant Use of PARP Inhibitor Shows Promise in Early-Stage, BRCA-Mutated Breast Cancer
ASCO Post, June 5, 2018 - Tailoring Chemotherapy Decisions – TAILORx Study Results
DJ Attai, Blog, June 4, 2018 - New approach to immunotherapy leads to complete response in breast cancer patient unresponsive to other treatments
NCI, June 4, 2018 - Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
JA Sparano et al, JM, June 3, 2018 - Elizabeth's breast cancer treatment didn't get in the way of her life
MSKCC, June 2018 - For Some Breast Cancer Patients, The Chemo Decision Just Got Easier
SK Watson, NPR, June 3, 2018 - Good News for Women With Breast Cancer: Many Don’t Need Chemo
D Grady, NY Times, June 2, 2018 - Many breast cancer patients can skip chemo, big study finds
M Marchionne, Stat News, June 3, 2018 - TAILORx trial finds most women with early breast cancer do not benefit from chemotherapy
NCI, June 3, 2018 - Despite risk of breast cancer, few men undergo genetic tests, study finds
E Rivero, UCLA News, May 31, 2018
.png)
No hay comentarios:
Publicar un comentario